Quantcast

Case activity for Aiesha Ferrell vs The Cooper Companies Inc. on Sept. 14

PENNSYLVANIA RECORD

Thursday, November 21, 2024

Case activity for Aiesha Ferrell vs The Cooper Companies Inc. on Sept. 14

Filings
General court 05

shutterstock.com

The U.S. District Court for the Eastern District of Pennsylvania reported the following activities in the suit brought by Aiesha Ferrell against Coopersurgical Inc., Duramed Pharmaceuticals Inc. a Division of Barr Pharmaceuticals, INC., D B a Teva Women's Health, INC., Teva Pharmaceuticals USA Inc., Teva Women's Health Inc., Indvidiually, and, Teva Women's Health LLC F K a Teva Women's Health, Inc., Teva Women's Health LLC, Individually and and The Cooper Companies Inc. on Sept. 14.

'Notice Of Removal By Teva Pharmaceuticals Usa Inc., Teva Women's Health, Llc, Individually And As Successor In Interest To Teva Women's Health, Inc., Coopersurgical, Inc., The Cooper Companies, Inc., Teva Women's Health, Llc F/k/a Teva Women's Health, Inc., Duramed Pharmaceuticals, Inc. A Division Of Barr Pharmaceuticals, Inc., D/b/a Teva Women's Health, Inc., Teva Women's Health Inc., Indvidiually, And As Successor In Interest To, Duramed Pharmaceuticals, Inc. A Division Of Barr Pharmaceuticals, Inc. (filing Fee $ 400 Receipt Number 0313-14562146), Filed By Teva Pharmaceuticals Usa Inc., Teva Women's Health, Llc, Individually And As Successor In Interest To Teva Women's Health, Inc., Coopersurgical, Inc., The Cooper Companies, Inc., Teva Women's Health, Llc F/k/a Teva Women's Health, Inc., Duramed Pharmaceuticals, Inc. A Division Of Barr Pharmaceuticals, Inc., D/b/A Teva Women's Health, Inc., Teva Women's Health Inc., Indvidiually, And As Successor In Interest To, Duramed Pharmaceuticals, Inc. A Division Of Barr Pharmaceuticals, Inc..(rubenstein, Brian)'

'Disclosure Statement Form Pursuant To Frcp 7.1 Including Vanguard Group, Inc. By The Cooper Companies, Inc..(rubenstein, Brian)'

'Disclosure Statement Form Pursuant To Frcp 7.1 Including The Cooper Companies, Inc. By Coopersurgical, Inc..(rubenstein, Brian)'

'Disclosure Statement Form Pursuant To Frcp 7.1 Including Teva Pharmaceutical Industries, Ltd. By Teva Pharmaceuticals Usa Inc..(rubenstein, Brian)'

'Disclosure Statement Form Pursuant To Frcp 7.1 Including Teva Pharmaceutical Industries, Ltd. By Teva Women's Health Inc., Indvidiually, And As Successor In Interest To, Duramed Pharmaceuticals, Inc. A Division Of Barr Pharmaceuticals, Inc..(rubenstein, Brian)'

'Disclosure Statement Form Pursuant To Frcp 7.1 Including Teva Pharmaceutical Industries, Ltd. By Teva Women's Health, Llc F/k/A Teva Women's Health, Inc..(rubenstein, Brian)'

'Answer To Complaint By Teva Women's Health Inc., Indvidiually, And As Successor In Interest To, Duramed Pharmaceuticals, Inc. A Division Of Barr Pharmaceuticals, Inc..(rubenstein, Brian)'

'Answer To Complaint By Teva Women's Health, Llc F/k/A Teva Women's Health, Inc..(rubenstein, Brian)'

Case number 2:20-cv-04483 was filed in the U.S. District Court for the Eastern District of Pennsylvania on Sept. 14.

More News